Ulysses Pharmaceuticals
Overcoming Antibiotic Resistance
Ulysses Pharmaceuticals is focused on discovery and development of novel antibiotics for empiric monotherapy to control resistant bacterial infections, extending the lives of patients in the hospital and in the community.

New Website Coming Soon!

Download our Fact Sheet
Microscope
  For all communications
Ulysses Pharmaceuticals
3201 Jean-Mignault Street
Sherbrooke (QC) Canada,  J1E 4K8


Michael Atkin
President & CEO
Phone: 514-989-7772 (Montreal)
Phone: 819-340-3144 (Sherbrooke)
Fax: 819-340-3141
matkin@ulyssespharma.com


roger léger, Ph.D.
Vice-President, R&D, Chemistry
Phone: 819-340-3144, ext. 10436
Fax: 819-340-3141
rleger@ulyssespharma.com
 
  © 2006-2007, Ulysses Pharmaceuticals -- All rights reserved